Bioactive Compounds
-
N1659 1-DeoxynojirimycinTarget: GlucosidasesSummary: anti-cancer medicine -
BA2351 TH1338Summary: TH1338, an orally active derivative of camptothecin, is a promising anticancer compound that exhibits excellent tumor cytotoxicity in vitro. -
C8383 Sulfo-Cy3-TetrazineSummary: Sulfo-Cy3-Tetraazine is a click chemistry containing a tetrazine moiety. -
BA3076 MIR96-IN-1Summary: MIR96-IN-1 targets the Drosha site in the hairpin precursor structure, inhibits its biogenesis, as well as inhibits downstream targets, and triggers apoptosis in breast cancer cells. -
M1088 4-Hydroxyphenylpyruvic acidSummary: An organic compound used to study the metabolic pathways of phenylpyruvic acid derivatives. -
C8782 Cinitapride Hydrogen TartrateSummary: Cinitapride Hydrogen Tartrate is a serotonergic and dopaminergic receptor modulator targeting 5-HT and D2 signaling, used in gastrointestinal motility and enteric neuropharmacology research. -
A7132 H-Cys-OH -
BA1120 FinafloxacinSummary: Fluoroquinolone anti-microbial agent with optimal efficacy in a slightly acidic environment. -
BA2349 Gly-7-MAD-MDCPTSummary: Gly-7-MAD-MDCPT is an anticancer agent. -
C8382 5-Br-PAPSSummary: 5-Br-PAPS is a Zn metal indicator with high specificity.

